North America Coronary Stents Market Report 2022 to 2030

North America Coronary Stents Market Analysis

$ 3999

This report presents a strategic analysis of the North America Coronary Stents Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the North America Coronary Stents Market, offering unmatched value, accuracy and expert insights.

ID: IN10NAMD006 CATEGORY: Medical Devices GEOGRAPHY: North America

Buy Now

North America Coronary Stents Market Executive Summary

North America's fastest-growing economy in 2021 was the United States. United States health spending is projected to have grown by 4.2% to $4.3 trillion in 2021, compared with a growth surge of 9.7% in 2020, according to the report from actuaries at the Centers for Medicare and Medicaid Services.

Total health spending in Canada reached a new level in 2021, at more than $308 billion, or $8,019 per Canadian. Health expenditure represented around 12.7% of Canada’s gross domestic product (GDP) in 2021, following a high of 13.7% in 2020. Governments and insurance stakeholders also need to discuss win-win reimbursement schemes that allow the democratization of telemedicine and provide lasting benefits for patients at an effective cost.

To develop universal health care, deal with medical emergencies, and encourage healthier populations, access to high-quality, reasonably priced, and suitable health products is essential.

Without medical devices, it would be impossible to do regular medical procedures like bandaging a damaged ankle, diagnosing HIV/AIDS, implanting an artificial hip, or performing any type of surgery. Medical gadgets are utilized by laypeople at home, paramedical workers and clinicians at outlying clinics, optometrists, dentists, and healthcare professionals in cutting-edge medical facilities, for screening and prevention, as well as in palliative care. These medical technologies are employed in the diagnosis and treatment of acute and chronic illnesses, as well as in the support of persons with disabilities.

In order to treat coronary heart disease, a coronary stent is a tube-shaped medical device inserted into the arteries supplying the heart. It keeps the arteries open. It is applied during a process known as percutaneous coronary intervention (PCI). More than 90% of PCI procedures also employ coronary stents. Stents have been proven to increase survival by lowering adverse events in acute myocardial infarction. They lessen angina, or chest discomfort, which is a common side effect.

Market Size and Key Findings

The North America Coronary Stents Market size is at around US $ 3.1 Bn in 2021 and is projected to reach US $ 4.41 Bn in 2030, exhibiting a CAGR of 7.28% during the forecast period.

North America Coronary Stents Market Size (In $Bn) (2021-2030F)

Market Dynamics

Market Growth Drivers Analysis

Over the projection period, demand for coronary stents is anticipated to be driven by an ageing population and an increase in the prevalence of risk factors such as cardiovascular diseases (CVDs), complicated lesions, diabetes, obesity, and others.

Market Restraints

Availability of alternative treatment methods for coronary artery disease, stringent regulations for product approval, product failure, and product recalls are the factors restraining the coronary stents market.

Competitive Landscape

Key Players

Major players in this market include Medtronic, plc (Ireland), Abbott Laboratories, Boston Scientific Corporation, Biosensors International Group, Ltd., BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, STENTYS SA, MicroPort Scientific Corporation, Meril Life Sciences Pvt. Ltd., Vascular Concepts, and Translumina GmbH. Product approvals, launches, and enhancements were the key strategies adopted by players to grow and expand their presence in the coronary stents market.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Coronary Stents Market Segmentation

By Type (Revenue, USD Billion):

The three main categories of coronary stents are bare-metal, drug-eluting, and bioabsorbable, depending on their nature. The segment for bioabsorbable stents is anticipated to increase at the fastest rate over the forecast period. The benefits that are encouraging the use of bioabsorbable stents include a decrease in problems including thrombosis and inflammation, the cNorth Americaity to restore normal vasomotion, and an improvement in aberrant endothelial function. However, in the upcoming years, the expansion of this market segment is anticipated to be constrained by the high cost of bioabsorbable stents.

Bare-metal Stents
Drug-eluting Stents
Bioabsorbable Stents

By Mode of Delivery (Revenue, USD Billion):

The market is divided into self-expanding and balloon-expandable stents according to delivery method. Because of the high use of these stents, rising research initiatives to advance the technology, and rising regulatory approvals for balloon-expandable stents, the balloon expandable stents segment is anticipated to increase at the greatest CAGR over the projection period.

Balloon-expandable Stents
Self-expanding Stents

By Materials (Revenue, USD Billion):

The coronary stent market is divided into metallic (cobalt chromium, platinum chromium, nickel-titanium, and stainless steel) and other stents according to the material. The market for other stents is anticipated to experience the largest CAGR growth during the projection period. The rapid expansion of this market can be ascribed to the increased use of polymers and copolymers in the production of bioabsorbable stents.

Metallic Stents
Cobalt-Chromium
Platinum Chromium
Nickel Titanium
Stainless Steel
Other Stents

By End User (Revenue, USD Billion):

The coronary stent market is divided into hospitals, cardiac centres, and ambulatory surgical centres based on the end user. According to predictions, the hospital sector will control the market in 2016. This is primarily caused by hospitals using a lot of coronary stents.

Hospitals
Cardiac Centers
Ambulatory Surgical Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.